Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 37.75
-0.80 (-2.08%)
Sep 24, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 5.26 billion as of September 25, 2026. Its market cap has increased by 31.99% in one year.
Market Cap
5.26B
Enterprise Value
7.46B
Revenue
1.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
37.75
ChartMarket Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 5.26B, an increase of 668.20%. That is a compound annual growth rate of 9.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 5.26B | 16.51% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 7.30B |
| Sinphar Pharmaceutical | 6.47B |
| Savior Lifetec | 6.43B |
| TaiGen Biopharmaceuticals Holdings | 6.30B |
| UnicoCell Biomed | 4.64B |
| Mycenax Biotech | 4.63B |
| Sinew Pharma | 4.28B |
| OBI Pharma | 4.27B |